ARTICLES
4,306 Article(s)
1, 2, 3, 4, 5, 6 >> >|
Document(s)
Title
Older patients with newly diagnosed acute myeloid leukemia (AML) in the phase 3 AZA-AML-001 study were evaluated at entry for cytogenetic abnormalities, and a subgroup of patients was assessed for gene mutations. Patients received azacitidine 75 mg/m...